Sight Sciences (SGHT) Free Cash Flow (2020 - 2026)
Sight Sciences' (SGHT) quarterly Free Cash Flow came in at -$7.1 million in Q1 2026, up 38.91% year-on-year from -$5.1 million in Q1 2025, and down 343.89% quarter-over-quarter from -$1.6 million in Q4 2025.
Sight Sciences (SGHT) Free Cash Flow (2020 - 2026) Analysis & Trends
Sight Sciences' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$7.1 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 38.91% year-over-year to -$7.1 million in Q1 2026; TTM through Mar 2026 was -$25.3 million, a 4.52% decrease from a year earlier, with the FY2025 full-year figure at -$29.8 million, down 33.22% from the prior year.
- Free Cash Flow eased to -$7.1 million in Q1 2026 per SGHT's latest filing, from -$1.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $311000.0 in Q3 2024 and bottomed at -$22.0 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$9.8 million (2024), against an average of -$10.8 million.
- Across the five-year window, Free Cash Flow surged 103.09% in 2024 and tumbled 2958.2% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$14.7 million in 2022, then soared by 55.63% to -$6.5 million in 2023, then surged by 49.89% to -$3.3 million in 2024, then soared by 51.04% to -$1.6 million in 2025, then plunged by 343.89% to -$7.1 million in 2026.
- Per Business Quant, the three latest SGHT Free Cash Flow figures stand at -$7.1 million (Q1 2026), -$1.6 million (Q4 2025), and -$8.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sight Sciences | 253.53 Mn | 168.57 Mn | 16.98 Mn | -7.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.09 Mn |
| Mar 31, 2026 | -7.09 Mn |
| Dec 31, 2025 | -1.60 Mn |
| Dec 31, 2025 | -1.60 Mn |
| Sep 30, 2025 | -8.89 Mn |
| Sep 30, 2025 | -8.89 Mn |
| Jun 30, 2025 | -7.75 Mn |
| Jun 30, 2025 | -7.75 Mn |
| Mar 31, 2025 | -11.61 Mn |
| Mar 31, 2025 | -11.61 Mn |
| Dec 31, 2024 | -3.26 Mn |
| Dec 31, 2024 | -3.26 Mn |
| Sep 30, 2024 | 311,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | -9.68 Mn |
| Jun 30, 2024 | -9.68 Mn |
| Mar 31, 2024 | -9.77 Mn |
| Mar 31, 2024 | -9.77 Mn |
| Dec 31, 2023 | -6.51 Mn |
| Dec 31, 2023 | -6.51 Mn |